{
    "clinical_study": {
        "@rank": "19965", 
        "arm_group": {
            "arm_group_label": "Vibrissae trimming", 
            "arm_group_type": "Experimental", 
            "description": "Patients will serve as their own control, with assessment of primary outcomes pre- and post-trimming of vibrissae."
        }, 
        "brief_summary": {
            "textblock": "Nasal obstruction is a common complaint prompting presentation to an otolaryngologist.  Many\n      studies have been performed quantifying and describing the impact of a number of factors on\n      symptoms of nasal obstruction, including anatomical, neoplastic, infectious, and\n      inflammatory causes.  Despite this scrutiny, no attention has been paid to the nasal\n      vibrissae as a potential anatomical contributor to nasal obstruction.  The proposed study\n      intends to elucidate that contribution, if any exists."
        }, 
        "brief_title": "The Effect of Nasal Hair on Nasal Obstruction", 
        "completion_date": {
            "#text": "October 2013", 
            "@type": "Actual"
        }, 
        "condition": "Nasal Obstruction", 
        "condition_browse": {
            "mesh_term": "Nasal Obstruction"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Presence of nasal vibrissae\n\n          -  Able to tolerate rhinomanometry\n\n        Exclusion Criteria:\n\n          -  Anatomical or other obvious cause of obstruction\n\n          -  Claustrophobia with rhinomanometry mask"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "60", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "May 3, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01850511", 
            "org_study_id": "12-001362"
        }, 
        "intervention": [
            {
                "arm_group_label": "Vibrissae trimming", 
                "description": "Patients will have oxymetazoline administered prior to assessment of outcome measures to ensure minimal impact of erectile mucosal tissue on measurement.", 
                "intervention_name": "Vibrissae trimming", 
                "intervention_type": "Procedure"
            }, 
            {
                "arm_group_label": "Vibrissae trimming", 
                "description": "Afrin will be administered to minimize the impact of erectile mucosal tissue on obstruction.", 
                "intervention_name": "Application of oxymetazoline", 
                "intervention_type": "Drug", 
                "other_name": "Afrin"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Oxymetazoline", 
                "Phenylephrine"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Nasal obstruction", 
            "Vibrissae", 
            "Nasal hair"
        ], 
        "lastchanged_date": "January 20, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Rochester", 
                    "country": "United States", 
                    "state": "Minnesota", 
                    "zip": "55905"
                }, 
                "name": "Mayo Clinic in Rochester"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "The Effect of Vibrissae on Subjective and Objective Measures of Nasal Obstruction", 
        "overall_official": {
            "affiliation": "Mayo Clinic", 
            "last_name": "Grant Hamilton, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "October 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": [
            {
                "description": "Objective measures include airflow and pressure as assessed by Rhinomanometry.", 
                "measure": "Nasal airflow/pressure", 
                "safety_issue": "No", 
                "time_frame": "Participants will undergo assessment over a 30 minute period, no follow-up"
            }, 
            {
                "description": "Subjective measures will be assessed via the modified version of the NOSE outcome instrument-a validated test of subjective nasal obstruction", 
                "measure": "Subjective Nasal Obstruction", 
                "safety_issue": "No", 
                "time_frame": "Participants will undergo assessment over a 30 minute period, no follow-up"
            }
        ], 
        "reference": {
            "PMID": "21447962", 
            "citation": "Ozturk AB, Damadoglu E, Karakaya G, Kalyoncu AF. Does nasal hair (vibrissae) density affect the risk of developing asthma in patients with seasonal rhinitis? Int Arch Allergy Immunol. 2011;156(1):75-80. doi: 10.1159/000321912. Epub 2011 Mar 30."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01850511"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Mayo Clinic", 
            "investigator_full_name": "David (Dave) G. Stoddard, Jr., M.D.", 
            "investigator_title": "Resident Physician, Department of Otolaryngology", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Mayo Clinic", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Mayo Clinic", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2013", 
        "study_design": "Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "January 2014"
    }
}